How to treat women with antiphospholipid antibodies in pregnancy?

Por DERKSEN, R, DE GROOT, P. G, NIEUWENHUIS, H, CHRISTIAENS, G
Publicado em 2001

Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment.

Por Derksen, R H, de Groot, P G, Kater, L, Nieuwenhuis, H K
Publicado em 1993

Treatment of women with aPL in pregnancy

Por FIEHN, C, DERKSEN, R, DE GROOT, P G, NIEUWENHUIS, H, CHRISTIAENS, G
Publicado em 2001

Prospective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus.

Por Out, H J, van Vliet, M, de Groot, P G, Derksen, R H
Publicado em 1992

Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion on subendothelium is not collagen.

Por de Groot, P G, Ottenhof-Rovers, M, van Mourik, J A, Sixma, J J
Publicado em 1988

Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.

Por Derksen, R H, Hasselaar, P, Blokzijl, L, Gmelig Meyling, F H, De Groot, P G
Publicado em 1988

Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study.

Por Out, H J, de Groot, P G, Hasselaar, P, dan Vliet, M, Derksen, R H
Publicado em 1989

Binding of recombinant annexin V to endothelial cells: effect of annexin V binding on endothelial-cell-mediated thrombin formation.

Por van Heerde, W L, Poort, S, van 't Veer, C, Reutelingsperger, C P, de Groot, P G
Publicado em 1994

Protein C activation on endothelial cells by prothrombin activation products generated in situ: meizothrombin is a better protein C activator than alpha-thrombin.

Por Hackeng, T M, Tans, G, Koppelman, S J, de Groot, P G, Rosing, J, Bouma, B N
Publicado em 1996

Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins.

Por Agbanyo, F R, Sixma, J J, de Groot, P G, Languino, L R, Plow, E F
Publicado em 1993

Absence of ligands bound to glycoprotein IIB-IIIA on the exposed surface of a thrombus may limit thrombus growth in flowing blood.

Por Heynen, H F, Lozano Molero, M, de Groot, P G, Nieuwenhuis, H K, Sixma, J J
Publicado em 1994

Risk factors for thrombosis in lupus patients.

Por Hasselaar, P, Derksen, R H, Blokzijl, L, Hessing, M, Nieuwenhuis, H K, Bouma, B N, De Groot, P G
Publicado em 1989

von Willebrand factor synthesized by endothelial cells from a patient with type IIB von Willebrand disease supports platelet adhesion normally but has an increased affinity for pla...

Por de Groot, P G, Federici, A B, de Boer, H C, d'Alessio, P, Mannucci, P M, Sixma, J J
Publicado em 1989

Increased platelet deposition on atherosclerotic coronary arteries.

Por van Zanten, G H, de Graaf, S, Slootweg, P J, Heijnen, H F, Connolly, T M, de Groot, P G, Sixma, J J
Publicado em 1994

Prevalence of antiphospholipid antibodies in patients with fetal loss.

Por Out, H J, Bruinse, H W, Christiaens, G C, van Vliet, M, Meilof, J F, de Groot, P G, Smeenk, R J, Derksen, R H
Publicado em 1991

Annexin A5 polymorphism (−1C→T) and the presence of anti‐annexin A5 antibodies in the antiphospholipid syndrome

Por de Laat, B, Derksen, R H W M, Mackie, I J, Roest, M, Schoormans, S, Woodhams, B J, de Groot, P G, van Heerde, W L
Publicado em 2006

Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and...

Por Sixma, J J, Sakariassen, K S, Stel, H V, Houdijk, W P, In der Maur, D W, Hamer, R J, de Groot, P G, van Mourik, J A
Publicado em 1984

Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure.

Por Bouma, B, de Groot, P G, van den Elsen, J M, Ravelli, R B, Schouten, A, Simmelink, M J, Derksen, R H, Kroon, J, Gros, P
Publicado em 1999

Elevated Plasma Surfactant Protein D (SP‐D) Levels and a Direct Correlation with Anti‐severe Acute Respiratory Syndrome Coronavirus‐specific IgG Antibody in SARS Patients

Por Wu, Y. P., Liu, Z. H., Wei, R., Pan, S. D., Mao, N. Y., Chen, B., Han, J. J., Zhang, F. S., Holmskov, U., Xia, Z. L., De Groot, P. G., Reid, K. B. M., Xu, W. B., Sorensen, G. L.
Publicado no Scand J Immunol (2009)